Regeneron President Booed At Conference Over Comments Urging Focus On Innovation Before Access

 
• By Sarah Karlin-Smith
  
Regeneron CSO and President George Yancopoulos
Regeneron’s Yancopoulos said access and equity are secondary problems when innovation is lacking for disease area. • Source: Milken Institue
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access